Table 4. Associations of high D-dimer with clinical outcomes.
| Total | Provoked DVT | Unprovoked DVT | |
|---|---|---|---|
| Recurrent VTE, HR (95% CI) | 3.51 (2.24–5.48) a | 4.56 (1.78–11.68) a | 3.16 (1.91–5.24) a |
| PTS, HR (95% CI) | 1.43 (0.93–2.20) | 1.46 (0.76–2.79) | 1.30 (0.72–2.34) |
| Arterial event, HR (95% CI) | 1.04 (0.50–2.17) | 1.01 (0.27–3.80) | 0.94 (0.39–2.28) |
| Cancer, HR (95% CI) | 0.67 (0.30–1.49) | 0.32 (0.08–1.23) a | 1.00 (0.42–2.37) |
Abbreviations: CI, confidence interval; DVT, deep vein thrombosis; HR, hazard ratio; PTS, post-thrombotic syndrome; VTE, venous thromboembolism.
Footnote: D-dimer levels were considered high at ≥ 500 ng/mL. Each association was adjusted for duration of anticoagulant therapy, age, and residual venous obstruction. Additionally, recurrent VTE was adjusted for unprovoked DVT, previous VTE, venous insufficiency and hypertension; PTS was adjusted for body mass index, venous insufficiency, iliofemoral DVT and smoking; arterial events were adjusted for hypertension, antiplatelet drug use and smoking; cancer was adjusted for hypertension.
p -Value <0.05.